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Aloe vera has been used worldwide both for pharmaceutical, food, and cosmetic industries due to the plethora of biological 
activities of some of its metabolites. A study case is reported focusing on the development of a cloning protocol of A. vera 
to provide propagation material with superior quality to the private sector in southern Brazil, i.e., A. vera juice industry. 
Such biotechnological approach afforded ca. 4,300 plantlets from 20 explants, over a 6-month period, overcoming the 
drawback of the lack of propagation material. Typically, the results have led to the increase of the cultured area and juice 
production of that species coming true the goal of the partnership between the public and private sectors herein involved. 
The transference of the resulting technology was successfully performed to the company and a patent covering the 
biotechnological process has been recently requested to official organisms on behalf of the partners. 
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  Historical evidences point to Africa as origin 
center of Aloe vera Müller, a species already cultured by 
Egyptian and Mediterranean people thousands of years B.C. 
Phytochemical studies have shown the presence of several 
bioactive compounds originated from Aloe vera’s primary 
and secondary metabolism pathways, which have been 
widely used in formulations (gels and juices, e.g.) in 
commercial scale all over the world. As example of those 
compounds is worth mentioning enzymes (lipases, 
bradykinases and proteases), mono e polysaccharides 
(glucomannans), amino acids, vitamins (A, B12, C and D), 
anthraquinones (aloine and emodine), saponins, salicilic 
acid, lignin and steroids (lupeol, campesterol, and 
sitosterol). A number of biological activities have been 
claimed to those substances, such as antiseptic [saponins 
and anthraquinones], anti-tumoral [mucopolysaccharides], 
anti-inflammatory [steroids and salicilic acid], antioxidant 
[vitamins], and immune-regulator [glucomannans] effects 
(Weiner & Weiner, 1994). Due to the wide spectrum of 
application in human health, the products containing A. 
vera’s compounds have showed a strong demand in both 
national and international markets. Accordingly, an 
increasing search for A. vera biomass of high quality can be 
envisages in local markets. However, since the biomass 
availability in Brazil is restricted, the expansion of this 
activity finds its “bottleneck”. In order to overcome this 
constraint, high yields should be a goal to be pursued in 
conventional cultures systems of Aloe vera, as well as the 
enlargement of the cultivated area. For that, a basic 
question should be addressed, i.e., the utilization of 
propagation material of high genetic and sanitary quality 
and its commercial availability.  
           
  Aloe vera is usually propagated through lateral 
shoots which the donor-plant produces mostly over the 
growth season. The number of lateral shoots/donor plant is 
low and also variable over time, becoming difficult to plan 
in a rational basis a production system in commercial scale 
for obtainment of plant propagation material. In general, 3 
to 4 lateral shoots/donor plant/year are found in 
conventional production systems, what is a time-consuming 
and tedious task, as well as an obviously meaningful 
drawback for purpose of large scale production of plant 
propagation material. In fact, this can be more easily 
visualized as one aims at obtaining propagation material to, 
for instance, 1 hectare, having a plant density of 12,000 to 
16,000 plants/ha, as usually found in commercial 
production systems. Additionally, a higher incidence of 
diseases is expected to happen due to lesions caused to 
donor-plant after withdrawing of the lateral shoots. 
 
  This picture points to a significant constraint 
concerning the availability of propagation material from A. 
vera with superior genetic and sanity qualities, so that the 
enlargement of the cultured area is a difficult task. 
Accordingly, the production of cosmetics, foods and 
pharmaceuticals containing A. vera has experienced a slow 
increase due to limited offering of raw material with high 
quality. 
 As a feasible solution for the production of higher 
quality propagation material of A. vera in large scale, 
biotechnological techniques have been thought of. Such 
approach has allowed the in vitro cloning and 
multiplication (by means of development of apical 
meristems as explants cultured in appropriate basal 
medium, for instance) in commercial scale of several plant 
species, as well as of superior germoplasms, being 
especially important for that recalcitrant species to 
conventional propagation techniques (cuttings and grafting, 
e.g.). 
  Over the last years, a micropropagation protocol 
for genotypes of A. vera was developed by Plant 
Morphogenesis and Biochemistry Laboratory (University 
Federal of Santa Catarina PMBL/UFSC) upon request and 
on behalf of small farmers, hereafter named Naturama 
Sucos Integrais do Brasil Ltd. Naturama is a small scale 
industry of A. vera juice in southern Brazil (Paulo Lopes 
county, Santa Catarina State), with an increasing 
participation in the local market. This partnership found 
financial support with the Brazilian Service for Support to 
Micro and Small Enterprises (SEBRAE/SC), a private 
institution that aims to promote the development of small 
producers in both rural and urban areas. Based in such a 
study case, some technical subjects are presented and 
discussed afterwards, which allowed in a consistent manner 
to increase the availability of A. vera’s propagation material 
to the partner company, with the consequent enlargement of 
the cultured area of that medicinal plant. Furthermore, it 
was possible to realize a significant decrease in the 
occurrence of diseases in the A. vera population at field 
conditions just by replacing of the plant propagation 
material obtained through conventional methods (lateral 
shoots) for the micropropagated one. The transference of 
the developed technology was successfully performed to 
the company and a patent for purpose of registration of the 
intellectual property has been recently requested to official 
organisms. To the best of our knowledge, no previous 
report has been published on the transference of a 
biotechnological product to the private sector, i.e., A. vera 
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  The protocol for micropropagation of Aloe vera 
was previously reported (Araújo et al. 2002). Briefly, the 
protocol was developed using apical meristems as explants 
cultured in basal medium of Murashige and Skoog (1962) – 
MS medium, supplemented with sucrose (3g%), agar 
(0.7%) and the growth regulators naphthalene acetic acid 
(4.03µM) and 6-benzylaminopurine (6.67µM). The in vitro 
multiplication rate (number of lateral shoots/explant) of 
sixteen A. vera genotypes furnished by small farmers and 
originated from Florianopolis and Araquari counties (Santa 
Catarina State), Pato Branco, Rolandia, and Colombo 
counties (Parana State) and also from Paraguay was 
assayed, over a 8 months period. During the experimental 
time the cultures were kept in growth chamber at 24±1°C, 
85% relative humidity of the air, 14-hour-photoperiod, and 
100 ± 5µM photons.m-2.s- (as active photosynthetic 
radiation), with a subculture interval of 35 days.  
 
  After the in vitro growth stage, plantlets taller than 
3cm were transferred to trays containing commercial 
substrate (Plantmax®) and kept at growth chamber under 
intermittent mist, for seven days. Further, the plantlets were 
transferred to plastic containers (~ 200mL internal volume) 
containing a mixture of soil and commercial substrate 
(Plantmax®, 1:1) and grown in greenhouse with periodic 
irrigation (3 days) and leaf manuring (15 and 21 day 
intervals, respectively for summer and winter seasons). 
After ca. two months growing under greenhouse conditions, 
the plantlets were directly transferred to field conditions, at 
Paulo Lopes county, and monitored over a 18-month period 
as to their agronomic treats (survival rate, phenological 
state evolution, resistance to pest and disease, and yield) 
and somaclonal variation occurrence (visual analysis of the 
phenotypes).   
Results 
 
    The data obtained for in vitro multiplication of the 
lateral shoots showed that experimental conditions induced 
a mean rate of new lateral shoots/explant of ca. 1:2. 
However, this value was strongly dependent of the 
genotype, i.e., the donor-plant, since a multiplication rate of 
1:8 was obtained as well. These findings suggest the 
existence of distinct morphogenetic potentials among the 
genotypes in study. More specifically the genotype 
originated from Paraguay showed the highest multiplication 
rate, with values ranging from 1:6 to 1:8 and was further 
selected to massal multiplication. Similar results have been 
reported for the micropropagation of other medicinal 
species with high commercial value as Coleus forskohlii, 
Camptotheca acuminate, and Valeriana edulis sp. procera, 
for instance (Pletsch, 1998). 
 
  The protocol used for multiplication of lateral 
shoots was also able in inducing the rhizogenesis, but in a 
time-dependent way. Thus, in all the cultures older than 35 
days were found platelets in different rooting stages, so that 
the subculture interval was changed to forty-five days. The 
data suggest that rhizogenesis induction is correlated, in any 
extension, to depletion of nutrients in culture medium. In 
fact, this methodology has allowed the obtainment of whole 
plants, i.e., aerial and rooting systems, without the need of 
transferring of the plantlets to rooting culture medium. 
Furthermore, in vitro rooting strongly influenced the 
survival rate of the plantlets over the acclimatization step. 
Notably, the rooted plantlets reached survival values of 
about 80% to 95%, as lower value was found to non-rooted 
plantlets (about 30% of survival). Interestingly, just after 
the transplant to commercial substrate, all the A. vera 
plantlets presented pronounced root degeneration, followed 
by the emission of new primary and secondary roots. In 
average, in vitro growth stage of the plantlets lasted for 
about 45-50 days, followed by an acclimatization step no 
longer than 2 months (spring and summer seasons) or 3 
months (autumn and winter seasons) without temperature 
control in the greenhouse.    
 
  The occurrence of individuals evidencing any 
phenotypic variation both in vitro or ex vitro was not 
detected over 18 months after transplantation to the field, 
except for two young plants which showed albinism and 
variegation in leaf tissue during the acclimatization step. 
Such findings probably results from somaclonal variation, a 
common phenomenon with aleatory occurrence in plant cell 
and tissue cultures that leads to the arising of variant 
phenotypes with genetic or epigenetic origin. Up to date, 
the results indicate that somaclonal variation is not a 
meaningful phenomenon as the protocol herein reported is 




  The described protocol seems to be technologically 
suitable for clonal multiplication of A. vera in large scale, 
affording propagation material with high genetic and 
sanitary quality. Over a 6-month-period, about 4,300 
plantlets were obtained in vitro from 20 initial explants, 
clearly revealing the potential of such a technological 
strategy to overcome the lack of propagation material of 
superior quality. Preliminary estimation point to a cost of 
ca. US$ 1, 00/plantlet (December - 2006), but it is assumed 
that the methodology herein described might be optimized 
in any extension, leading to a reduction in that value. 
However, comparatively to the conventional propagation 
system used to A. vera the results herein shown are 
significantly superior. In fact, it was possible to produce a 
large number of propagation materials, which are presently 
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in cultivation by the partner company, in a less expensive 
and time-consuming way. Additionally, this 
biotechnological approach has allowed the increase of the 
economic activity of Naturama Sucos Integrais do Brasil 
Ltd. as technological improvements in its A. vera juice 
production system are claimed and are matter of currently 
concerns. In a near future, it is possible to envisage the 
complete autonomy of that company property regarding 
both the production of A. vera raw material and its 
transformation to juices and other derivative products (i.e., 
nutraceuticals).  
 
  In a more wide sense, the adoption of this 
biotechnological strategy could, in any extension and taking 
into account the specific conditions of each enterprise, be 
applied as a model (“tailor made”) to increase the incoming 
of Aloe-related companies, as a short-term goal, since it 
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